Completed OBSERVATIONAL NCT01188356

EMERALD - AssEssment of CoMorbidities & Atrial ArRhythmiA Burden in DuaL-Chamber PaceD Patients (EMERALD)

AssEssment of CoMorbidities & Atrial ArRhythmiA Burden in DuaL-Chamber PaceD Patients

Sponsor: MicroPort CRM

Updated 8 times since 2017 Last updated: Mar 21, 2019 Started: Mar 31, 2010 Primary completion: Apr 30, 2015 Completion: Aug 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01188356, this observational or N/A phase trial focuses on Atrial Arrhythmia and remains completed. Sponsored by MicroPort CRM, it has been updated 8 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Apr 2019 — Jan 2021 [monthly]

Completed

▶ Show 3 earlier versions

Jun 2018 — Apr 2019 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Status: Active Not Recruiting → Completed · Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Active Not Recruiting NA

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MicroPort CRM

Data source: MicroPort CRM

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aix-en-Provence, France , Albi, France , Alicante, Spain , Alten, Germany , Anaheim, United States , Annaberg-Buchholz, Germany , Annecy, France , Arezzo, Italy , Arlon, Belgium , Arnstadt, Germany and 152 more locations